Billionaire Stanley Druckenmiller’s Dividend Stocks Include Merck

Page 1 of 2

We track 13F filings from hedge funds and other notable investors for a variety of purposes. First, we have found that the most popular small cap stocks among hedge funds earn an average excess return of 18 percentage points per year (learn more about our small cap strategy) and we are looking for other potential strategies. Second, we like to review top picks from investment managers and treat them as a source of free recommendations for further research. When we went through the 13F from billionaire Stanley Druckenmiller (who previously managed Duquesne Capital and was also a top portfolio manager for George Soros) we noticed a number of high yield stocks among his top picks (see the full list of stocks Druckenmiller reported owning). Here are five stocks which Druckenmiller had over $20 million invested in at the beginning of January and which pay dividend yields of 3.5% or higher going by current prices and recent dividend policy:

One of the billionaire’s five largest holdings by market value was his 2.4 million shares of Merck & Co., Inc. (NYSE:MRK), which was 22% more shares than he had owned three months earlier. As a large pharmaceutical company, Merck does not have much exposure to economic conditions and so the stock’s beta is 0.4. The dividend yield is nearly 4%, though the company did report lower revenue and earnings last quarter than in the fourth quarter of 2011. Merck had made our list of the most popular healthcare stocks among hedge funds for the fourth quarter of 2012 (find more healthcare stocks hedge funds loved).

DUQUESNE CAPITALDruckenmiller did cut his stake in fellow drug manufacturer Eli Lilly & Co. (NYSE:LLY) but still owned 1.4 million shares of the $61 billion market cap company. That valuation places Eli Lilly at 15 times trailing earnings, though revenue and earnings were both down slightly in the fourth quarter of 2012 versus a year earlier and so it’s not necessarily a value stock. The dividend yield here is 3.5%, with a beta similar to Merck’s. Renaissance Technologies, founded by billionaire Jim Simons, reported a position of 8.1 million shares at the end of December (check out Renaissance's stock picks).

The billionaire also liked a number of utilities paying high dividend yields:

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!